News about Industrial talks

FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences

FUJIFILM Irvine Scientific Rebrands as FUJIFILM Biosciences

FUJIFILM Irvine Scientific has officially rebranded as FUJIFILM Biosciences, formalising the Life Sciences Group restructuring announced in June and reflecting its expanded life sciences portfolio built on over 55 years of cell culture expertise.

Industrial talks | 06/01/2026 | By News Bureau 137

US FDA Advances Review of Tzield in Young Children

US FDA Advances Review of Tzield in Young Children

The FDA has accepted Sanofi’s sBLA for Tzield under priority review, seeking broader pediatric use in delaying type 1 diabetes onset.

Industrial talks | 06/01/2026 | By News Bureau 168

India Reaffirms Commitment to Traditional Medicine at 9th Siddha Day Celebrations in Chennai

India Reaffirms Commitment to Traditional Medicine at 9th Siddha Day Celebrations in Chennai

The 9th Siddha Day celebrations highlighted India’s traditional systems of medicine as living, holistic and preventive healthcare practices, with a strong focus on Siddha’s relevance to modern and global health needs.

Industrial talks | 05/01/2026 | By News Bureau 158

Orum Therapeutics Appoints Dr Chad May as Chief Scientific Officer

Orum Therapeutics Appoints Dr Chad May as Chief Scientific Officer

Orum Therapeutics has appointed Dr Chad May, PhD, as Chief Scientific Officer (CSO), who brings over two decades of oncology and immunology research experience to advance the company’s degrader-antibody conjugate platform and pipeline of next-generation therapies.

Industrial talks | 05/01/2026 | By News Bureau 181

Manoj Joshi Assumes Charge as Secretary, Department of Pharmaceuticals

Manoj Joshi Assumes Charge as Secretary, Department of Pharmaceuticals

Senior Indian Administrative Service officer Manoj Joshi has taken charge as the new Secretary of the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers, following approval by the Appointments Committee of the Cabinet.

Industrial talks | 03/01/2026 | By Darshana 281

New Leadership Elected at Telangana State Chemists and Druggists Association

New Leadership Elected at Telangana State Chemists and Druggists Association

With the start of the new year, the Telangana State Chemists and Druggists Association (TSCDA) has ushered in a new phase of leadership following the completion of its state-level elections. The polls were conducted on Sunday at the TSCDA Bhavan in Hyderabad, with members from across Telangana participating to elect the association’s new office-bearers.

Industrial talks | 02/01/2026 | By Darshana 240

Quality, Compliance and Market Diversification to Drive India's Pharma Export Strategy in 2026: Pharmexcil

Quality, Compliance and Market Diversification to Drive India's Pharma Export Strategy in 2026: Pharmexcil

India’s pharmaceutical export industry is preparing for 2026 with a sharp focus on quality excellence, regulatory compliance and diversification into new global markets, according to the Pharmaceuticals Export Promotion Council of India (Pharmexcil).

Industrial talks | 02/01/2026 | By Darshana 359

Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal

Valneva and Serum Institute End Chikungunya Vaccine Licensing Deal

Valneva SE and the Serum Institute of India have mutually agreed to discontinue their licensing agreement for Valneva’s single-shot chikungunya vaccine, bringing the collaboration to a close by mutual consent.

Industrial talks | 01/01/2026 | By News Bureau 123

Cogent Biosciences Submits NDA for Bezuclastinib in Non Advanced Systemic Mastocytosis

Cogent Biosciences Submits NDA for Bezuclastinib in Non Advanced Systemic Mastocytosis

Cogent Biosciences has submitted a New Drug Application to the US FDA for bezuclastinib in non-advanced systemic mastocytosis, supported by positive results from the SUMMIT pivotal trial and following its Breakthrough Therapy Designation for patients with smouldering systemic mastocytosis and previously treated NonAdvSM.

Industrial talks | 31/12/2025 | By News Bureau 213

Evogene Appoints Dr Olga Nissan as VP for Business Development

Evogene Appoints Dr Olga Nissan as VP for Business Development

Evogene has appointed Dr Olga Nissan as Vice President of Business Development, effective 1 January, 2026, bringing to the role a seasoned biotechnology and pharmaceutical leader with extensive experience spanning R&D, clinical development and business operations across pharma, diagnostics and agri-biotechnology sectors.

Industrial talks | 31/12/2025 | By News Bureau 122

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members